Drug Information Analysis Service

Brown CS Rakel RE Wells BG Downs JM Akiskal HS . A practical update on anxiety disorders and their pharmacologic treatment. Arch Intern Med 1991; 151: 873–84.

Redmond DE . New and old evidence for the involvement of a brain norepinephrine system in anxiety. In: Fann WE Karacan I Pokorny AD Williams RL , eds. Phenomenology and treatment of anxiety. New York: Spectrum Publications, 1979: 153–203.

Nutt DJ . Increased central alpha₂-adrenoceptor sensitivity in panic disorder. Psychopharmacol 1986; 90: 268–9.

Charney DS Heninger GR . Abnormal regulation of noradrenergic function in panic disorders. Arch Gen Psychiatry 1986; 43: 1042–54.

Uhde TW Vittone BJ Siever LJ Kaye WH Post RM . Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry 1986; 21: 1081–5.

Stein MB Uhde TW . Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Biol Psychiatry 1988; 24: 322–30.

Nutt DJ . Altered central alpha₂-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989; 46: 165–9.

Liebowitz MR Fyer AJ McGrath P Klein DF . Clonidine treatment of panic disorder. Psychopharmacology Bulletin 1981; 17: 122–3.

Cassano GB Perugi G McNair DM . Panic disorder: review of the empirical and rational basis of pharmacological treatment. Pharmacopsychiatry 1988; 21: 157–65.

Svensson TH Bunney BS Aghajanian GK . Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 1975; 92: 291–306.

Hoehn-Saric R Merchant AF Keyser ML Smith VK . Effects of clonidine on anxiety disorders. Arch Gen Psychiatry 1981; 38: 1278–82.

Charney DS Menkes DB Heninger GR . Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 1981; 38: 1160–80.

Uhde TW Stein MB Vittone BJ Siever LJ Boulenger JP Klein E Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry 1989; 46: 170–7.

Higham J Shaw R . Risk-benefit assessment of drugs used for the treatment of menstrual disorders. Drug Saf 1991; 6 (3): 183–91.

Eijkeren M Christiaens G Scholten P Sixma J . Menorrhagia: current drug treatment concepts. Drugs 1992; 43 (2): 201–9.

Smith SK Abel MH Kelly RW Baird DT . Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981; 88: 434–42.

Ylikorkala O Pekonene F . Naproxen reduces idiopathic but not fibryomyoma-induced menorrhagia. Obstet Gynecol 1986; 68: 10–2.

Fraser IS McCarron G Markham R Robinson M Smyth E . Long-term treatment of menorrhagia with mefenamic acid. Obstet Gynecol 1983; 61: 109–12.

Vargyas JM Campeau JD Mishell DR . Treatment of menorrhagia with meclofenamate sodium. Am J Obstet Gynecol 1987; 157: 944–50.

Adelantado J Rees M Bernal A Turnbull A . Increased uterine prostaglandin E receptors in menorrhagic women. Br J Obstet Gynaecol 1988; 95: 162–5.

Makarainen L Ylikorkala O . Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen. Br J Obstet Gynaecol 1986; 93: 974–8.

Elder MG . Prostaglandins and menstrual disorders. Br Med J 1993; 287: 703–4.

Fraser IS Pearse C Shearman RP Elliot PM McIlveen J Markham R . Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstet Gynecol 1981; 58: 543–51.

Anderson A Guillebaud J Haynes P Turnbull A . Reduction of menstrual blood loss by prostaglandin-synthetase inhibitors. Lancet 1976; 1: 774–6.

Cameron I Haining R Lumsden M Thomas V Smith S . The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol 1990; 76: 85–8.

Dockeray C Sheppard B Bonnar J . Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. Br J Obstet Gynaecol 1989; 96: 840–4.

Hall P Maclachlan N Thorn N Nudd M Taylor D Garrioch D . Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid. Br J Obstet Gynaecol 1987; 94: 554–8.

Chamberlain G Freeman R Price F Kennedy A Green P Eve L . A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991; 98: 707–11.

Andersch B Milsom I Rybo G . An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstet Gynecol Scand 1988; 67: 645–8.

Milsom I Andersson K Andersch B Rybo G . A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991; 164: 879–82.

Reybrouck G . Antiseptic drugs and disinfectants. Meyler's side effects of drugs, annual 8. New York: Elsevier, 1984: 243.

Valdes-Dapena MA Arey JB . Boric acid poisoning. J Pediatr 1962; 61: 531–45.

Keller-Van-Slyke K Michel VP Rein MF . The boric acid powder treatment of vulvovaginal candidiasis. College Health 1981; 30: 107–9.

Swate TE Weed JC . Boric acid treatment of vulvovaginal candidiasis. Obstet Gynecol 1974; 43: 893–5.

Jovanovic R Congema E Nguyen HT . Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis. J Reprod Med 1991; 36: 593–7.

Schou JS Jansen JA Aggerbeck B . Human pharmacokinetics and safety of boric acid. Arch Toxicol 1984; (suppl 7): 232–5.

Dousset G . Penetration du bore organique dans le liquide cethalorhachildien de la ratte gestante. Compt Rendu (Paris) 1971; 165: 722–4.

Heinonen OP Slone D Shapiro S . Birth defects and drugs in pregnancy. Littleton, MA: Publishing Science Group, 1977: 311.

Cleeves L Findley LJ . Tremors. Med Clin North Am 1989; 73: 1307–19.

Koller WC . A new drug for the treatment of essential tremor? Time will tell. Mayo Clin Proc 1991; 66: 1085–7.

Clifford DB . Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol 1983; 13: 669–71.

Meinck HM Schoule PW Conrad B . Effects of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 1989; 236: 120–2.

Frankel JP Hughes A Lees AJ Stern GM . Marijuana for Parkinsonian tremor (letter). J Neurol Neurosurg Psychiatry 1990; 53: 436.